Skip to main content
OTCMKTS:HRBR

Harbor Diversified Competitors

$1.70
-0.10 (-5.56 %)
(As of 05/14/2021 12:00 AM ET)
Add
Compare
Today's Range
$1.59
$1.82
50-Day Range
$0.65
$2.05
52-Week Range
$0.04
$2.20
Volume98,995 shs
Average Volume181,758 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
Beta2.07

Competitors

Harbor Diversified (OTCMKTS:HRBR) Vs. ACUS, AFFY, ARYX, AHROQ, CBPI, and CDSG

Should you be buying HRBR stock or one of its competitors? Companies in the industry of "pharmaceutical preparations" are considered alternatives and competitors to Harbor Diversified, including Acusphere (ACUS), Affymax (AFFY), ARYx Therapeutics (ARYX), AtheroNova (AHROQ), China Botanic Pharmaceutical (CBPI), and China Dongsheng International (CDSG).

Harbor Diversified (OTCMKTS:HRBR) and Acusphere (OTCMKTS:ACUS) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their risk, institutional ownership, analyst recommendations, earnings, profitability, dividends and valuation.

Profitability

This table compares Harbor Diversified and Acusphere's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Harbor DiversifiedN/AN/AN/A
AcusphereN/AN/AN/A

Risk & Volatility

Harbor Diversified has a beta of 2.07, indicating that its stock price is 107% more volatile than the S&P 500. Comparatively, Acusphere has a beta of -0.25, indicating that its stock price is 125% less volatile than the S&P 500.

Earnings and Valuation

This table compares Harbor Diversified and Acusphere's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Harbor Diversified$263.61 millionN/A$-19,210,000.00N/AN/A
AcusphereN/AN/AN/AN/AN/A

Acusphere has lower revenue, but higher earnings than Harbor Diversified.

Analyst Ratings

This is a breakdown of current ratings and recommmendations for Harbor Diversified and Acusphere, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Harbor Diversified0000N/A
Acusphere0000N/A

Summary

Harbor Diversified beats Acusphere on 2 of the 2 factors compared between the two stocks.

Harbor Diversified (OTCMKTS:HRBR) and Affymax (OTCMKTS:AFFY) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, dividends, valuation, analyst recommendations, earnings, profitability and institutional ownership.

Profitability

This table compares Harbor Diversified and Affymax's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Harbor DiversifiedN/AN/AN/A
AffymaxN/AN/AN/A

Risk & Volatility

Harbor Diversified has a beta of 2.07, indicating that its stock price is 107% more volatile than the S&P 500. Comparatively, Affymax has a beta of 2.77, indicating that its stock price is 177% more volatile than the S&P 500.

Valuation & Earnings

This table compares Harbor Diversified and Affymax's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Harbor Diversified$263.61 millionN/A$-19,210,000.00N/AN/A
AffymaxN/AN/AN/AN/AN/A

Affymax has lower revenue, but higher earnings than Harbor Diversified.

Analyst Recommendations

This is a summary of recent ratings for Harbor Diversified and Affymax, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Harbor Diversified0000N/A
Affymax0000N/A

Harbor Diversified (OTCMKTS:HRBR) and ARYx Therapeutics (OTCMKTS:ARYX) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, dividends, valuation, analyst recommendations, earnings, profitability and institutional ownership.

Profitability

This table compares Harbor Diversified and ARYx Therapeutics' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Harbor DiversifiedN/AN/AN/A
ARYx TherapeuticsN/AN/AN/A

Risk & Volatility

Harbor Diversified has a beta of 2.07, indicating that its stock price is 107% more volatile than the S&P 500. Comparatively, ARYx Therapeutics has a beta of -0.53, indicating that its stock price is 153% less volatile than the S&P 500.

Valuation & Earnings

This table compares Harbor Diversified and ARYx Therapeutics' revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Harbor Diversified$263.61 millionN/A$-19,210,000.00N/AN/A
ARYx TherapeuticsN/AN/AN/AN/AN/A

ARYx Therapeutics has lower revenue, but higher earnings than Harbor Diversified.

Analyst Recommendations

This is a summary of recent ratings for Harbor Diversified and ARYx Therapeutics, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Harbor Diversified0000N/A
ARYx Therapeutics0000N/A

Summary

Harbor Diversified beats ARYx Therapeutics on 2 of the 2 factors compared between the two stocks.

Harbor Diversified (OTCMKTS:HRBR) and AtheroNova (OTCMKTS:AHROQ) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, dividends, valuation, analyst recommendations, earnings, profitability and institutional ownership.

Profitability

This table compares Harbor Diversified and AtheroNova's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Harbor DiversifiedN/AN/AN/A
AtheroNovaN/AN/AN/A

Risk & Volatility

Harbor Diversified has a beta of 2.07, indicating that its stock price is 107% more volatile than the S&P 500. Comparatively, AtheroNova has a beta of -8.71, indicating that its stock price is 971% less volatile than the S&P 500.

Valuation & Earnings

This table compares Harbor Diversified and AtheroNova's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Harbor Diversified$263.61 millionN/A$-19,210,000.00N/AN/A
AtheroNovaN/AN/AN/AN/AN/A

AtheroNova has lower revenue, but higher earnings than Harbor Diversified.

Analyst Recommendations

This is a summary of recent ratings for Harbor Diversified and AtheroNova, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Harbor Diversified0000N/A
AtheroNova0000N/A

Summary

Harbor Diversified beats AtheroNova on 2 of the 2 factors compared between the two stocks.

Harbor Diversified (OTCMKTS:HRBR) and China Botanic Pharmaceutical (OTCMKTS:CBPI) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, dividends, valuation, analyst recommendations, earnings, profitability and institutional ownership.

Risk & Volatility

Harbor Diversified has a beta of 2.07, indicating that its stock price is 107% more volatile than the S&P 500. Comparatively, China Botanic Pharmaceutical has a beta of 17.09, indicating that its stock price is 1,609% more volatile than the S&P 500.

Analyst Recommendations

This is a summary of recent ratings for Harbor Diversified and China Botanic Pharmaceutical, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Harbor Diversified0000N/A
China Botanic Pharmaceutical0000N/A

Profitability

This table compares Harbor Diversified and China Botanic Pharmaceutical's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Harbor DiversifiedN/AN/AN/A
China Botanic PharmaceuticalN/AN/AN/A

Valuation & Earnings

This table compares Harbor Diversified and China Botanic Pharmaceutical's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Harbor Diversified$263.61 millionN/A$-19,210,000.00N/AN/A
China Botanic PharmaceuticalN/AN/AN/AN/AN/A

China Botanic Pharmaceutical has lower revenue, but higher earnings than Harbor Diversified.

China Dongsheng International (OTCMKTS:CDSG) and Harbor Diversified (OTCMKTS:HRBR) are both consumer staples companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, analyst recommendations, profitability, valuation, earnings, risk and institutional ownership.

Risk and Volatility

China Dongsheng International has a beta of 13.38, indicating that its stock price is 1,238% more volatile than the S&P 500. Comparatively, Harbor Diversified has a beta of 2.07, indicating that its stock price is 107% more volatile than the S&P 500.

Analyst Ratings

This is a summary of recent recommendations and price targets for China Dongsheng International and Harbor Diversified, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
China Dongsheng International0000N/A
Harbor Diversified0000N/A

Profitability

This table compares China Dongsheng International and Harbor Diversified's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
China Dongsheng InternationalN/AN/AN/A
Harbor DiversifiedN/AN/AN/A

Earnings and Valuation

This table compares China Dongsheng International and Harbor Diversified's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
China Dongsheng InternationalN/AN/AN/AN/AN/A
Harbor Diversified$263.61 millionN/A$-19,210,000.00N/AN/A

China Dongsheng International has higher earnings, but lower revenue than Harbor Diversified.


Harbor Diversified Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
Acusphere logo
ACUS
Acusphere
0.0$0.05-24.4%$0.00N/A0.00Gap Up
Affymax logo
AFFY
Affymax
0.6$0.09-23.5%$0.00N/A0.00High Trading Volume
Gap Down
ARYX
ARYx Therapeutics
0.0$0.02-46.7%$0.00N/A0.00High Trading Volume
Gap Up
AHROQ
AtheroNova
0.0$0.01-0.0%$0.00N/A0.00
CBPI
China Botanic Pharmaceutical
0.0$0.08-6.0%$0.00N/A0.00Gap Up
China Dongsheng International logo
CDSG
China Dongsheng International
0.3$0.06-0.0%$0.00N/A0.00
China Health Industries logo
CHHE
China Health Industries
0.4$0.25-0.0%$0.00$9.93 million4.20Upcoming Earnings
DDXSQ
Diadexus
0.0N/AN/A$0.00N/A0.00
ERBA
ERBA Diagnostics
0.8$0.04-0.0%$0.00N/A0.00
FTCY
Global Future City
0.5$0.00-0.0%$0.00N/A0.00
GLSI
Greenwich LifeSciences
2.0$32.95-3.6%$0.00N/A0.00Gap Down
IPAH
Interpharm
0.2$0.00-0.0%$0.00N/A0.00
IRBS
IR Biosciences
0.0$0.00-0.0%$0.00N/A0.00
MBVXQ
MabVax Therapeutics
0.0$0.02-8.7%$0.00N/A0.00Gap Down
MYRX
Myrexis
0.5$0.05-4.8%$0.00N/A0.00
NNBP
Nanobac Pharmaceuticals
0.0$0.00-0.0%$0.00N/A0.00
PARD
Poniard Pharmaceuticals
0.5$0.09-0.0%$0.00N/A0.00
SGTI
Shengtai Pharmaceutical
0.2$0.02-0.0%$0.00N/A0.00
SKBI
Skystar Bio-Pharmaceutical
0.5$0.00-0.0%$0.00N/A0.00
SUWN
Sunwin Stevia International
0.5$0.05-2.2%$0.00$26.09 million0.00Gap Up
Sycamore Entertainment Group logo
SEGI
Sycamore Entertainment Group
0.3$0.03-0.0%$0.00N/A0.00Gap Down
SYNI
Synvista Therapeutics
0.0$0.00-0.0%$0.00N/A0.00
TPIY
Tianyin Pharmaceutical
0.6$0.00-0.0%$0.00N/A0.00High Trading Volume
Tibet Pharmaceuticals logo
TBET
Tibet Pharmaceuticals
0.0$0.01-3.0%$0.00N/A0.00High Trading Volume
Gap Down
VOQP
VioQuest Pharmaceuticals
0.0$0.01-0.0%$0.00N/A0.00
This page was last updated on 5/16/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.